Supplement FAQ: EFA-Sirt Supreme®

by Biotics Research

Why you may need EFA-Sirt Supreme®:

Both cardiovascular health and blood lipid profiles are of increasing concern to many people.  For optimal health, lifestyle modification may not be enough, and a variety of strategic supplementation may be warranted.  EFA-Sirt Supreme® supplies a unique, highly concentrated essential fatty acid blend, providing an extremely effective relative combination of EPA, DHA and GLA, with all natural mixed tocopherols, specially formulated to be high in γ-Tocopherol.  A large amount of supportive scientific research shows that the  consumption of Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA) Omega- 3 fatty acids may reduce the risk of coronary heart disease.  Omega-3 fatty acids have been shown to affect platelet aggregation, blood viscosity, plasma levels of fibrinogen, PF4 and beta-thromboglobulin and capillary flow.  These effects are believed to be functions of membrane fluidity.  Omega-3 fatty acids support healthy blood lipid profiles, normal healthy blood pressure, stimulate Nitric Oxide (NO) and support healthy, normal blood sugar and insulin levels.  Omega-3 fatty acids help to suppress ACE, TGA beta, SREBP and function as PPAR agonists.  Additionally, Omega-3 fatty acid supplementation increases fatty acid oxidation, which research suggests helped to decrease adipose tissue and serves to improve endothelial function.  DHA is not only essential for neural function, but it is an important
component of cell membranes and supports normal healthy blood pressure.  DHA is converted by several mechanisms into docosatrienes and resolvins, which have anti-inflammatory properties.  According to the research, their activity may very well be due to the fatty acids effects modifying genetic expression.  Gamma linolenic acid (GLA), the good Omega-6 fatty acid, is elongated to DGLA, the biologically active form from which eicosanoids are derived.  DGLA metabolites reduce the formation of arachadonate-derived prostaglandins, leukotrienes, plateletactivating factors, and supports normal healthy blood pressure.  Collectively, this superior combination of essential fatty acids provide a balance of key nutrients that current research has shown to support healthy cardiovascular function.

Why your healthcare practitioner recommends EFA-Sirt Supreme® from Biotics Research:

Following several years of research and clinical evaluations, Dr. Mark Houston, Associate Clinical Professor of Medicine at Vanderbilt Medical School and Director of Hypertension Institute and Vascular Biology in Nashville, in conjunction with scientists at Biotics Research Corporation, developed a unique essential fatty acid supplement: EFA-Sirt Supreme®. Each serving of EFA-Sirt Supreme® supplies, on average, 750 mg of GLA, 900 mg of EPA, and 600 mg of DHA, making it a superior fatty acid supplement and an ideal stand alone product or adjunct to VasculoSirt®, ResveraSirt-HP®, and CoQ-Zyme 30™.  This unique EFA blend is available exclusively through Biotics Research Corp.  As always, Biotics Research Corporation brings you “The Best of Science and Nature”.

Click here to download the Patient FAQ on EFA-Sirt Supreme® from Biotics Research in a printable PDF.


Tags: ,

Leave a Reply

Biotics Research Corporation has been a leading manufacturer of specially designed nutritional products for over thirty years. Our mission remains constant: to be the benchmark of excellence in nutritional science, technology and service, providing the clinician with reliable, innovative products of superior quality as well as the highest level of customer service.

Click here to subscribe to the The Bio-Blog via email!

Click here
to become our Fan on Facebook!